The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency

Mathew Sheridan(University of Manchester), Georges Lacaud(Cancer Research UK Manchester Institute)
Journal of Hematology & Oncology
October 8, 2024
Cited by 9


Related Papers